Esophagogastric Junction Neoplasms
2 clinical trials · Condition
◉ Watch Esophagogastric Junction Neoplasms
| Record | Firm | Date |
|---|---|---|
| CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors (NCT04660929) | Carisma Therapeutics Inc | 2021-02-02 |
| Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors (NCT02658214) | AstraZeneca | 2016-04-28 |
Track Esophagogastric Junction Neoplasms automatically
Every clearance here is in the API, with alerts when new ones post.